Matthew Stent

Matthew Stent is currently the President - Head of Business Development Europe at Navin Molecular, a CDMO division of Navin Fluorine that focuses on producing small molecule intermediates and starting materials. Previously, Matthew held various roles at Navin Fluorine International Ltd., including President - BD Europe & Key Accounts and President - Head of Project Management. With a background in organic chemistry, Matthew also worked at Key Organics and University of Texas at Austin in research and leadership positions. Overall, Matthew has extensive experience in project management, business development, and chemistry services within the pharmaceutical and related industries.